Macrolides as anti-inflammatory agents in CAP

Waleed Salih, Philip M. Short, Stuart Schembri

Source: Eur Respir Monogr 2014; 63: 243-255
Disease area: Respiratory infections

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Waleed Salih, Philip M. Short, Stuart Schembri. Macrolides as anti-inflammatory agents in CAP. Eur Respir Monogr 2014; 63: 243-255

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Novel anti-inflammatory agents
Source: Annual Congress 2009 - Emerging trends in the therapy of COPD
Year: 2009


Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia
Source: Eur Respir J 2015; 46: 876-877
Year: 2015


Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia
Source: Eur Respir J 2015; 46: 875-876
Year: 2015


Macrolides, mucoactive drugs and adherence for the management of bronchiectasis
Source: Eur Respir J, 51 (1) 1702033; 10.1183/13993003.02033-2017
Year: 2018



Macrolides, mucoactive drugs and adherence for the management of bronchiectasis
Source: Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017
Year: 2018



Mucolytics and anti-inflammatory lung treatments
Source: ERS course 2015
Year: 2015


Non-steroidal anti-inflammatory drug use and clinical outcomes of community-acquired pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018



Anti-inflammatory therapies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 223-238
Year: 2011


Azithromycin in the anti-inflammatory treatment of children with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

Long-term macrolide therapy in chronic inflammatory airway diseases
Source: Eur Respir J 2009; 33: 171-181
Year: 2009



Non-antibiotic therapies for CAP
Source: Eur Respir Monogr 2014; 63: 219-233
Year: 2014


Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia : A cohort study
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016


Update on anti-inflammatory therapy in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


Drugs anti-inflammatories
Source: Virtual Congress 2020 – Management
Year: 2020


Switching of antimicrobial agents in the therapy of community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Next generation of anti-inflammatory therapy for COPD?
Source: Eur Respir J, 50 (4) 1702084; 10.1183/13993003.02084-2017
Year: 2017



Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004